Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allegra for Pruritic Skin Disease
NCT00261079Phase 4Completed
- Sponsor
- Handok
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fexofenadine in pruritus, sponsored by Handok. Started Apr 2005; status: completed.
02
Drugs
fexofenadine
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT00261079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261079.